ArticleNeurogastroenterology and motility2024

Most patients with disorders of gut-brain interaction receive pharmacotherapy with major or moderate drug-gene interactions.

Revati Varma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.